“Pfizer and Aid Groups Team Up to Offer Contraceptive for the Developing World”
The New York Times, November 14, 2014, p.B3
“Depo-Provera, an injectable contraceptive given once every three months, is already a popular choice of women in developing countries, who value the convenience and discretion of not having to take a daily birth control pill. But the injections are out of reach for many more women because they live in rural areas that are too far from a health clinic to make the treatments practical. Now, a major collaboration between Pfizer, the drug’s manufacturer, and several global aid groups is aiming to change that by providing financing to make a new version of the drug — redesigned with developing countries in mind — available in 69 nations throughout Africa, Asia, Latin America and Eastern Europe. The new product, called the Sayana Press, is a single-use syringe designed to be portable and easy to use. … The product is already being used in several African countries, but Pfizer said it planned to expand distribution through a financial partnership that would allow the product, which typically costs about $1.50 a dose, to be sold to health care institutions in those countries for about $1. Several groups, including the Bill and Melinda Gates Foundation and the Children’s Investment Fund Foundation, as well as the United States Agency for International Development, will help subsidize the cost and assist in introducing it in countries around the globe. Women will most likely receive the product free or at a reduced cost.”
Quickie Analysis: Perhaps this will be a game-changer for women in the developing world, the way the Pill was for women in the developed world.